{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:08:37Z","timestamp":1791065317460,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI077774"],"award-info":[{"award-number":["P01AI077774"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.molmed.2026.03.009","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:47:37Z","timestamp":1776174457000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Creutzfeldt\u2013Jakob disease is an Alzheimer\u2019s disease-related dementia"],"prefix":"10.1016","author":[{"given":"Joel C.","family":"Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J.","family":"Sigurdson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Yobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3412-0524","authenticated-orcid":false,"given":"Claudio","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2026.03.009_bb0005","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer\u2019s disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.molmed.2026.03.009_bb0010","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/S0140-6736(24)01883-X","article-title":"Passive anti-amyloid \u03b2 immunotherapy in Alzheimer's disease\u2014opportunities and challenges","volume":"404","author":"Heneka","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2026.03.009_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-024-00497-y","article-title":"Creutzfeldt-Jakob disease and other prion diseases","volume":"10","author":"Zerr","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.molmed.2026.03.009_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.03.009_bb0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1139\/bcb-2024-0018","article-title":"The importance of prion research","volume":"102","author":"Eid","year":"2024","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0030","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2026.03.009_bb0035","first-page":"31","article-title":"A\u03b2 plaques","volume":"1","author":"Walker","year":"2020","journal-title":"Free Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12792","article-title":"Classification of diseases with accumulation of Tau protein","volume":"48","author":"Kovacs","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/cjn.2022.34","article-title":"Current concepts of mixed pathologies in neurodegenerative diseases","volume":"50","author":"Forrest","year":"2023","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.molmed.2026.03.009_bb0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41591-023-02729-2","article-title":"Iatrogenic Alzheimer\u2019s disease in recipients of cadaveric pituitary-derived growth hormone","volume":"30","author":"Banerjee","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2026.03.009_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.03.009_bb0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature20415","article-title":"Mammalian prions and their wider relevance in neurodegenerative diseases","volume":"539","author":"Collinge","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.03.009_bb0070","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral \u03b2-amyloidogenesis is governed by agent and host","volume":"313","author":"Meyer-Luehmann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.03.009_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40478-018-0529-x","article-title":"Prion-like propagation of \u03b2-amyloid aggregates in the absence of APP overexpression","volume":"6","author":"Ruiz-Riquelme","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.molmed.2026.03.009_bb0080","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.03.009_bb0085","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"Watts","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.03.009_bb0090","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2026.03.009_bb0100","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41593-020-00737-w","article-title":"Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life","volume":"23","author":"Uhlmann","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2026.03.009_bb0105","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","article-title":"\u03b1-synuclein immunotherapy blocks uptake and templated propagation of misfolded \u03b1-synuclein and neurodegeneration","volume":"7","author":"Tran","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.03.009_bb0110","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.neuron.2025.03.008","article-title":"Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signatures","volume":"113","author":"Scialo","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2026.03.009_bb0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev-pathmechdis-012418-013109","article-title":"Cellular and molecular mechanisms of prion disease","volume":"14","author":"Sigurdson","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0120","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.molmed.2026.03.009_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186432","article-title":"Mutant prion protein enhances NMDA receptor activity, activates PKC, and triggers rapid excitotoxicity in mice","volume":"135","author":"Lin","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2026.03.009_bb0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1566524043360618","article-title":"The peripheral nervous system and the pathogenesis of prion diseases","volume":"4","author":"Glatzel","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.molmed.2026.03.009_bb0135","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1099\/vir.0.81999-0","article-title":"Patterns of PrPCWD accumulation during the course of chronic wasting disease infection in orally inoculated mule deer (Odocoileus hemionus)","volume":"87","author":"Fox","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0140","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1099\/0022-1317-79-3-601","article-title":"Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie","volume":"79","author":"Beekes","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.molmed.2026.03.009_bb0150","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2026.03.009_bb0155","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3233\/JPD-212570","article-title":"Constipation is associated with development of cognitive impairment in de novo Parkinson\u2019s disease: a longitudinal analysis of two international cohorts","volume":"11","author":"Leta","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.molmed.2026.03.009_bb0160","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied A\u03b2-containing inoculates induce cerebral \u03b2-amyloidosis","volume":"330","author":"Eisele","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.03.009_bb0165","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1038\/s41380-021-01150-w","article-title":"Transmission of cerebral amyloid pathology by peripheral administration of misfolded A\u03b2 aggregates","volume":"26","author":"Morales","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2026.03.009_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-017-1762-2","article-title":"MSA prions exhibit remarkable stability and resistance to inactivation","volume":"135","author":"Woerman","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","volume":"23","author":"Challis","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2026.03.009_bb0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00401-025-02957-5","article-title":"Co-infection with two \u03b1-synuclein strains reveals novel synergistic interactions","volume":"150","author":"Holec","year":"2025","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.celrep.2014.02.031","article-title":"Detection of misfolded A\u03b2 oligomers for sensitive biochemical diagnosis of Alzheimer's disease","volume":"7","author":"Salvadores","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2026.03.009_bb0190","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","article-title":"Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid","volume":"74","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00401-018-1947-3","article-title":"Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease","volume":"137","author":"Kraus","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0205","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.tibtech.2024.01.007","article-title":"\u03b1-Synuclein seed amplification technology for Parkinson\u2019s disease and related synucleinopathies","volume":"42","author":"Soto","year":"2024","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-023-02574-0","article-title":"Tau seeds occur before earliest Alzheimer\u2019s changes and are prevalent across neurodegenerative diseases","volume":"146","author":"Manca","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0215","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/35081095","article-title":"Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding","volume":"411","author":"Saborio","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.03.009_bb0220","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2026.03.009_bb0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cell.2005.02.011","article-title":"In vitro generation of infectious scrapie prions","volume":"121","author":"Castilla","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2026.03.009_bb0230","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.51057","article-title":"Transmission of CJD from nasal brushings but not spinal fluid or RT-QuIC product","volume":"7","author":"Raymond","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.03.009_bb0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-022-00283-4","article-title":"Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy","volume":"11","author":"Martinez-Valbuena","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.molmed.2026.03.009_bb0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s40478-021-01282-8","article-title":"High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease","volume":"9","author":"Russo","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.molmed.2026.03.009_bb0250","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","article-title":"Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies","volume":"29","author":"Okuzumi","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2026.03.009_bb0255","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0260","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41467-025-56469-7","article-title":"Early Alzheimer\u2019s disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathy","volume":"16","author":"Browne","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.03.009_bb0265","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1474-4422(25)00157-7","article-title":"Diagnostic and prognostic value of \u03b1-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study","volume":"24","author":"Orru","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105925","article-title":"\u03b1-Synuclein seed amplification assay positivity beyond synucleinopathies","volume":"120","author":"Martinez-Valbuena","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molmed.2026.03.009_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00401-020-02201-2","article-title":"The existence of A\u03b2 strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease","volume":"142","author":"Lau","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00401-020-02163-5","article-title":"Evidence of distinct \u03b1-synuclein strains underlying disease heterogeneity","volume":"142","author":"Holec","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-021-02301-7","article-title":"Tau strains shape disease","volume":"142","author":"Vaquer-Alicea","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0290","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-023-06437-2","article-title":"Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids","volume":"621","author":"Scheres","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.03.009_bb0295","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1016\/j.molcel.2021.08.011","article-title":"High-resolution structure and strain comparison of infectious mammalian prions","volume":"81","author":"Kraus","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2026.03.009_bb0300","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1038\/s41467-022-30457-7","article-title":"2.7 A cryo-EM structure of ex vivo RML prion fibrils","volume":"13","author":"Manka","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2026.03.009_bb0305","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41589-022-01229-7","article-title":"A structural basis for prion strain diversity","volume":"19","author":"Manka","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0310","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-022-02461-0","article-title":"Cryo-EM structures of prion protein filaments from Gerstmann\u2013Str\u00e4ussler\u2013\u2013Scheinker disease","volume":"144","author":"Hallinan","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0315","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","article-title":"Structure-based classification of tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.03.009_bb0320","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70039","article-title":"The evolution of experimental rodent models for prion diseases","volume":"169","author":"DeFranco","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molmed.2026.03.009_bb0325","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41586-025-09698-1","article-title":"Synthetic \u03b1-synuclein fibrils replicate in mice causing MSA-like pathology","volume":"648","author":"Burger","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.03.009_bb0330","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1073\/pnas.1301175110","article-title":"Brain homogenates from human tauopathies induce tau inclusions in mouse brain","volume":"110","author":"Clavaguera","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2026.03.009_bb0335","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/brain\/awab374","article-title":"Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology","volume":"145","author":"Teil","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2026.03.009_bb0340","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2026.03.009_bb0345","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/brain\/awv006","article-title":"Rapidly progressive Alzheimer's disease features distinct structures of amyloid-\u03b2","volume":"138","author":"Cohen","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2026.03.009_bb0350","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1474-4422(20)30273-8","article-title":"Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study","volume":"19","author":"Jones","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0355","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s004010050870","article-title":"Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease","volume":"96","author":"Hainfellner","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0360","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1126\/science.1132661","article-title":"Infectious prions in the saliva and blood of deer with chronic wasting disease","volume":"314","author":"Mathiason","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.03.009_bb0365","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08289","article-title":"Asymptomatic deer excrete infectious prions in faeces","volume":"461","author":"Tamg\u00fcney","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.03.009_bb0370","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2026.03.009_bb0375","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/bs.pmbts.2017.06.010","article-title":"Infectious and sporadic prion diseases","volume":"150","author":"Knight","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.molmed.2026.03.009_bb0380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","article-title":"Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy","volume":"525","author":"Jaunmuktane","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2026.03.009_bb0385","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-017-1703-0","article-title":"Amyloid-\u03b2 accumulation in the CNS in human growth hormone recipients in the UK","volume":"134","author":"Ritchie","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2026.03.009_bb0390","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jnnp-2022-328792","article-title":"Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon","volume":"93","author":"Banerjee","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.molmed.2026.03.009_bb0395","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJMc2000687","article-title":"Variant Creutzfeldt-Jakob disease diagnosed 7.5 years after occupational exposure","volume":"383","author":"Brandel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2026.03.009_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106820","article-title":"Current safety recommendations for handling mouse and human \u03b1synuclein pre-formed fibrils","volume":"206","author":"Fielding","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molmed.2026.03.009_bb0405","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.1222951","article-title":"Cell biology. A unifying role for prions in neurodegenerative diseases","volume":"336","author":"Prusiner","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.molmed.2026.03.009_bb0410","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41576-018-0011-4","article-title":"Prions, prionoids and protein misfolding disorders","volume":"19","author":"Scheckel","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2026.03.009_bb0415","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","article-title":"Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases","volume":"21","author":"Jucker","year":"2018","journal-title":"Nat. Neurosci."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426000808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491426000808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:47:47Z","timestamp":1776174467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491426000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":83,"alternative-id":["S1471491426000808"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2026.03.009","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Creutzfeldt\u2013Jakob disease is an Alzheimer\u2019s disease-related dementia","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2026.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}